Vanguard Group’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.25M Buy
779,473
+2,068
+0.3% +$21.9K ﹤0.01% 3009
2025
Q1
$11.7M Buy
777,405
+12,135
+2% +$182K ﹤0.01% 2762
2024
Q4
$12.6M Sell
765,270
-33,373
-4% -$549K ﹤0.01% 2820
2024
Q3
$19.7M Buy
798,643
+8,507
+1% +$210K ﹤0.01% 2594
2024
Q2
$20M Buy
790,136
+16,434
+2% +$416K ﹤0.01% 2568
2024
Q1
$19.7M Buy
773,702
+9,657
+1% +$245K ﹤0.01% 2608
2023
Q4
$17.3M Sell
764,045
-3,752
-0.5% -$85K ﹤0.01% 2659
2023
Q3
$14.3M Sell
767,797
-192,909
-20% -$3.59M ﹤0.01% 2690
2023
Q2
$25M Sell
960,706
-21,497
-2% -$558K ﹤0.01% 2500
2023
Q1
$28.2M Sell
982,203
-1,565
-0.2% -$44.9K ﹤0.01% 2442
2022
Q4
$29.1M Sell
983,768
-3,600
-0.4% -$107K ﹤0.01% 2456
2022
Q3
$23.5M Buy
987,368
+12,125
+1% +$289K ﹤0.01% 2558
2022
Q2
$21.8M Sell
975,243
-10,252
-1% -$229K ﹤0.01% 2600
2022
Q1
$24.7M Buy
985,495
+19,582
+2% +$492K ﹤0.01% 2655
2021
Q4
$34.6M Buy
965,913
+13,535
+1% +$485K ﹤0.01% 2548
2021
Q3
$40.5M Sell
952,378
-5,323
-0.6% -$227K ﹤0.01% 2477
2021
Q2
$41.5M Buy
957,701
+37,203
+4% +$1.61M ﹤0.01% 2469
2021
Q1
$37.5M Sell
920,498
-13,784
-1% -$562K ﹤0.01% 2461
2020
Q4
$42.3M Buy
934,282
+23,246
+3% +$1.05M ﹤0.01% 2289
2020
Q3
$32.2M Sell
911,036
-2,207
-0.2% -$78.1K ﹤0.01% 2240
2020
Q2
$34.5M Sell
913,243
-10,122
-1% -$382K ﹤0.01% 2184
2020
Q1
$26.7M Buy
923,365
+7,769
+0.8% +$225K ﹤0.01% 2161
2019
Q4
$47.5M Sell
915,596
-4,363
-0.5% -$226K ﹤0.01% 2132
2019
Q3
$50.5M Buy
919,959
+3,701
+0.4% +$203K ﹤0.01% 2059
2019
Q2
$37.2M Buy
916,258
+3,182
+0.3% +$129K ﹤0.01% 2252
2019
Q1
$27.6M Buy
913,076
+33,425
+4% +$1.01M ﹤0.01% 2356
2018
Q4
$29.6M Buy
879,651
+18,082
+2% +$608K ﹤0.01% 2269
2018
Q3
$36.3M Buy
861,569
+8,799
+1% +$371K ﹤0.01% 2302
2018
Q2
$27.3M Buy
852,770
+16,598
+2% +$531K ﹤0.01% 2428
2018
Q1
$41.6M Buy
836,172
+1,202
+0.1% +$59.8K ﹤0.01% 2166
2017
Q4
$45M Buy
834,970
+4,622
+0.6% +$249K ﹤0.01% 2112
2017
Q3
$48.2M Buy
830,348
+23,309
+3% +$1.35M ﹤0.01% 2061
2017
Q2
$39.8M Buy
807,039
+15,797
+2% +$779K ﹤0.01% 2124
2017
Q1
$34.4M Sell
791,242
-53,802
-6% -$2.34M ﹤0.01% 2177
2016
Q4
$41.4M Buy
845,044
+12,889
+2% +$631K ﹤0.01% 2074
2016
Q3
$39.8M Buy
832,155
+14,931
+2% +$714K ﹤0.01% 2036
2016
Q2
$43.8M Buy
817,224
+75,648
+10% +$4.06M ﹤0.01% 1959
2016
Q1
$33.2M Buy
741,576
+102,614
+16% +$4.59M ﹤0.01% 2065
2015
Q4
$24.4M Buy
638,962
+6,941
+1% +$265K ﹤0.01% 2217
2015
Q3
$20.1M Buy
632,021
+32,197
+5% +$1.02M ﹤0.01% 2288
2015
Q2
$19.8M Sell
599,824
-62,416
-9% -$2.06M ﹤0.01% 2359
2015
Q1
$27.3M Buy
662,240
+9,391
+1% +$387K ﹤0.01% 2198
2014
Q4
$26.6M Buy
652,849
+41,791
+7% +$1.7M ﹤0.01% 2135
2014
Q3
$22.4M Buy
611,058
+63,557
+12% +$2.33M ﹤0.01% 2160
2014
Q2
$25.4M Buy
547,501
+75,752
+16% +$3.51M ﹤0.01% 2127
2014
Q1
$19.4M Buy
471,749
+96
+0% +$3.95K ﹤0.01% 2196
2013
Q4
$18M Buy
471,653
+61,676
+15% +$2.35M ﹤0.01% 2207
2013
Q3
$9.82M Sell
409,977
-3,947
-1% -$94.6K ﹤0.01% 2407
2013
Q2
$7.04M Buy
+413,924
New +$7.04M ﹤0.01% 2492